Fate Therapeutics (FATE)
Fate Therapeutics (FATE) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- FATE last traded at $0.96 on 2026-11-20, -5.06% for the session.
- Fate Therapeutics: market cap $116.57M, revenue $4.75M over the last four quarters.
- Over the past year FATE returned -8.68%, with a year-to-date return of -2.41%.